Your browser doesn't support javascript.
loading
Inequality factors in access to early-phase clinical trials in oncology in France: results of the EGALICAN-2 study.
Charton, E; Baldini, C; Fayet, Y; Schultz, E; Auroy, L; Vallier, E; Italiano, A; Robert, M; Coquan, E; Isambert, N; Moreau, P; Touzeau, C; Le Tourneau, C; Ghrieb, Z; Kiladjian, J-J; Delord, J-P; Gomez Roca, C; Vey, N; Barlesi, F; Lesimple, T; Penel, N; Soria, J-C; Massard, C; Besle, S.
Afiliação
  • Charton E; Human and Social Sciences Department, Centre Léon Bérard, Lyon. Electronic address: emilie.charton@lyon.unicancer.fr.
  • Baldini C; Drug Development Department (DITEP), Gustave Roussy, Paris-Saclay University, Villejuif.
  • Fayet Y; Human and Social Sciences Department, Centre Léon Bérard, Lyon; Research on Healthcare Performance (RESHAPE), INSERM U1290, Lyon.
  • Schultz E; CEPED (UMR 196), University of Paris, IRD, Paris; SESSTIM, CANBIOS Team, Aix-Marseille University, INSERM, IRD, Marseille.
  • Auroy L; University of Grenoble Alpes, CNRS, Sciences Po Grenoble, Grenoble.
  • Vallier E; Human and Social Sciences Department, Centre Léon Bérard, Lyon; Drug Development Department (DITEP), Gustave Roussy, Paris-Saclay University, Villejuif.
  • Italiano A; Bergonié Institute, Bordeaux.
  • Robert M; Medical Oncology Department, Institut de Cancérologie de l'Ouest, Saint-Herblain.
  • Coquan E; Medical Oncology Department, Centre François Baclesse, Caen.
  • Isambert N; Medical Oncology Department, University Hospital of Poitiers, Poitiers.
  • Moreau P; Medical Oncology Department, Centre Georges-François Leclerc, Dijon.
  • Touzeau C; Department of Hematology, University Hospital of Nantes, Nantes.
  • Le Tourneau C; Department of Drug Development and Innovation, Institut Curie, Paris.
  • Ghrieb Z; Service de Pharmacologie et Investigations Cliniques, Hôpital Saint-Louis, AP-HP, Paris.
  • Kiladjian JJ; Service de Pharmacologie et Investigations Cliniques, Hôpital Saint-Louis, AP-HP, Paris.
  • Delord JP; Institut Claudius Regaud, IUCT-Oncopole, Toulouse.
  • Gomez Roca C; Institut Claudius Regaud, IUCT-Oncopole, Toulouse.
  • Vey N; Department of Hematology, Institut Paoli-Calmettes, Marseille.
  • Barlesi F; CRCM, INSERM, CNRS, APHM, Aix-Marseille University, Marseille; Gustave Roussy, Villejuif.
  • Lesimple T; Department of Oncology, Eugene Marquis Center, Rennes.
  • Penel N; Centre Oscar Lambret, Lille University, Lille.
  • Soria JC; Drug Development Department (DITEP), Gustave Roussy, Paris-Saclay University, Villejuif.
  • Massard C; Drug Development Department (DITEP), Gustave Roussy, Paris-Saclay University, Villejuif.
  • Besle S; Human and Social Sciences Department, Centre Léon Bérard, Lyon; Drug Development Department (DITEP), Gustave Roussy, Paris-Saclay University, Villejuif; Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de recherche en cancérologie de Lyon, Institut Convergence PLA
ESMO Open ; 8(4): 101610, 2023 08.
Article em En | MEDLINE | ID: mdl-37536254
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: ESMO Open Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: ESMO Open Ano de publicação: 2023 Tipo de documento: Article